Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Anticancer therapeutic potential of benzofuran scaffolds
Ashraf A. Abbas, Kamal M. Dawood
RSC Advances (2023) Vol. 13, Iss. 16, pp. 11096-11120
Open Access | Times Cited: 43
Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)
Yufeng An, Xinya Lv, Shidi Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117268-117268
Closed Access
Olaparib research update: mechanism, structure and clinical trials
Hao Che, Liwei Wang, Xiang‐Yang Ye, et al.
Medicinal Chemistry Research (2025)
Closed Access
Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition
Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Unexpected products using Biginelli reaction: Synthesis, antimicrobial potency, docking simulation, and DFT investigations of some new amidopyridines
Nabila A. Kheder, Asmaa M. Fahim, Naglaa S. Mahmoud, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136772-136772
Closed Access | Times Cited: 14
Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis
Doaa M. Mohamed, Nabila A. Kheder, Marwa Sharaky, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24992-25006
Open Access | Times Cited: 4
Recent advances on quinoxalines as target‐oriented chemotherapeutic anticancer agents through apoptosis
Mohamed S. Nafie, S. Kahwash, Magdy M. Youssef, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Closed Access | Times Cited: 3
Multi-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment
Jie Zhang, Yuqi Gao, Zipeng Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16099-16127
Closed Access | Times Cited: 20
Synthesis, crystal structure, DFT, Hirshfeld surface analysis, energy frameworks and in-Silico drug-targeting PFKFB3 kinase of novel triazolequinoxalin derivative (TZQ) as a therapeutic Strategy against cancer
Nadeem Abad, Fares Hezam Al-Ostoot, Sajda Ashraf, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21312-e21312
Open Access | Times Cited: 9
Synthetic Methods and Pharmacological Potentials of Triazolothiadiazines: A Review
Mohamed S. Mostafa, Ibrahim Ali M. Radini, Naglaa M. Abd El‐Rahman, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1326-1326
Open Access | Times Cited: 2
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 7
Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine) Derivatives as EGFR/CDK-2 Target Inhibitors
Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, et al.
ACS Omega (2023) Vol. 8, Iss. 38, pp. 35359-35369
Open Access | Times Cited: 6
Recent developments in the chemistry of 1H- and 4H-1,2,4-triazoles
Ashraf A. Abbas, Kamal M. Dawood
Advances in heterocyclic chemistry (2023), pp. 209-273
Closed Access | Times Cited: 4
Bis(ethanones) and their derivatives: Versatile precursors for bis(heterocycles)
Ahmed H. M. Elwahy, Mohamed R. Shaaban, Ismail A. Abdelhamid
Advances in heterocyclic chemistry (2023), pp. 227-276
Closed Access | Times Cited: 4
Clean and Efficient Green Protocol of N,N′-Bis(2-(arylazo)-2-(aroyl)vinyl)ethane-1,2-diamines in Aqueous Medium without Catalyst: Synthesis and Photophysical Characterization
Abdulrahman M. Alazemi, Kamal M. Dawood, Hamad M. Al‐Matar, et al.
ACS Omega (2024) Vol. 9, Iss. 48, pp. 47532-47542
Open Access
In Vitro and In Vivo Effects of Synthesis Novel Phenoxyacetamide Derivatives as Potent Apoptotic Inducer against HepG2 Cells through PARP-1 Inhibition
M Sayed, Zohour I. Nabil, Nahla S. El‐Shenawy, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1524-1524
Open Access | Times Cited: 1
Page 1

Scroll to top